Isturisa — United Healthcare
endogenous hypercortisolemia in adults with Cushing’s syndrome for whom surgery is not an option or has not been curative
Initial criteria
- Diagnosis of Cushing’s syndrome
- AND
- One of the following:
- Patient is not a candidate for pituitary surgery
- OR
- Pituitary surgery has not been curative
Reauthorization criteria
- Documentation of positive response to Isturisa therapy
Approval duration
12 months